Sunwin´´wo hin ?
Seite 12 von 67 Neuester Beitrag: 24.04.21 23:45 | ||||
| Eröffnet am: | 19.07.06 11:39 | von: Jonni | Anzahl Beiträge: | 2.65 |
| Neuester Beitrag: | 24.04.21 23:45 | von: Mandyajisa | Leser gesamt: | 437.400 |
| Forum: | Hot-Stocks | Leser heute: | 43 | |
| Bewertet mit: |  | |||
| Seite: < 1 | ... | 9 | 10 | 11 | | 13 | 14 | 15 | ... 67 > | ||||
Studies Back Sweetener's Safety - WSJ.com
By BETSY MCKAY
May 15, 2008; Page D6
A set of scientific studies probing the health effects and stability of a calorie-free natural sweetener that Cargill Inc. and Coca-Cola Co. aim to market are expected to be published Thursday, offering evidence of its safety, according to people familiar with the research.
The findings were funded by Cargill and are being published online in the journal Food and Chemical Toxicology. The results could put the two companies one step closer toward gaining U.S. regulatory approval for their sweetener, which is derived from the South American herb stevia.
The companies hope the sweetener, which bears the brand name Truvia and the common name rebiana, will give them a lock on the "holy grail" of sweeteners: one that sweetens foods and beverages naturally, has no calories and tastes good.
Stevia isn't approved for use as a food additive in the U.S. Studies over the past two decades on its health effects have logged in a number of problems, from research in 1985 finding potential mutations in the livers of rats to concerns about fertility problems in men. Some countries banned stevia after the 1985 findings. In the early 1990s, the Food and Drug Administration concluded that there wasn't enough data available to demonstrate stevia's safety as a food additive, although it later allowed it to be sold as a dietary supplement.
Coke and Cargill dispute the 1985 study and have said their new product differs from the unrefined versions of stevia used in early tests. A more recent World Health Organization report found no major toxicity risks, but said more data are needed on the herb's effect on hypertension and blood-sugar levels, given some concerns that high doses of stevia compounds may lower blood pressure or blood-sugar levels in diabetics.
The studies being published Thursday explored those questions and others. The series of animal studies and human clinical trials found that consumption of the sweetener didn't affect blood-sugar control in Type 2 diabetics, and it had no major effect on blood pressure of healthy adults, among other questions. A study of rats explored the sweetener's effect on male and female reproductive systems.
The companies said last year that they would move to market the sweetener in 12 countries where it is approved as a food additive, including Japan, Brazil and China. But limited supply means it will take some time before it is widely available.
Cargill sees Truvia on U.S. market by year-end | Markets | Markets News | Reuters
NEW YORK, May 15 (Reuters) - Agribusiness and commodity trading group Cargill Inc [CARG.UL] said on Thursday that it expects its natural, no-calorie sweetener to be on the U.S. market by the end of the year.
In an interview, Marcelo Montero, president of Cargill's Health and Nutrition unit, said the product, to be called Truvia, will be available this year as a tabletop sweetener.
Cargill, which has developed Truvia in partnership with Coca-Cola Co (KO.N: Quote, Profile, Research), said it has notified U.S. health regulators of the safety of Truvia, which is made from the leaves of a shrub called stevia that is native to Paraguay. (Reporting by Martinne Geller, editing by Gerald E. McCormick)
By Martinne Geller
NEW YORK, May 15 (Reuters) - Agribusiness and commodity trading group Cargill Inc [CARG.UL] said on Thursday that it expects its no-calorie sweetener made from a South American shrub to be on the U.S. market by the end of the year.
In an interview, Marcelo Montero, president of Cargill's Health and Nutrition unit, said the product, called rebiana, will be available this year as a tabletop sweetener.
Rebiana, which will be sold under the name Truvia, is made from the leaves of a shrub called stevia that is native to Paraguay and will provide a natural alternative to chemical sweeteners including Sweet'N Low and Equal.
Stevia is not approved as a food additive by health regulators in the United States or the European Union, though it can be sold as a dietary supplement. It is approved in a dozen countries, including Japan, China and Brazil.
Privately-held Cargill, which is handling the growing of the plants and the regulatory process, said it has notified the U.S. Food and Drug Association that Truvia is safe, based on scientific studies being published on Thursday in the journal "Food and Chemical Toxicology."
The company said FDA approval typically takes anywhere from two to six months.
Montero said Cargill is working with a number of companies on projects involving the sweetener, but declined to give a timeline for the launch of other rebiana-sweetened food products.
A spokesman for Coca-Cola Co (KO.N: Quote, Profile, Research), which co-developed the product with Cargill and has exclusive rights to use it in beverages, also declined to offer a schedule.
"We'll certainly explore the different applications," said Coke spokesman Kelly Brooks.
Most full-calorie soft drinks sold in the United States are sweetened with high-fructose corn syrup, a cheap alternative to cane sugar. But corn syrup has been criticized for contributing to obesity and has soared in price due to climbing demand for ethanol, which is also made from corn.
Lower-calorie sodas are now made with artificial sweeteners such as saccharin, aspartame and sucralose, which are sold under the respective brand names of Sweet'N Low, NutraSweet and Equal, and Splenda, which is made by Tate & Lyle Plc (TATE.L: Quote, Profile, Research).
Drinks sweetened with rebiana would likely appeal to health-conscious consumers and natural grocers, such as Whole Foods Market Inc (WFMI.O: Quote, Profile, Research), that tend to carry products made from natural ingredients.
One of Cargill's rebiana suppliers, GLG Life Tech Corp (GLG.TO: Quote, Profile, Research), said earlier this month that it started building a 500-metric-ton stevia processing facility in Qingdao, China. (Editing by Brian Moss)
Truvia™ - Nature's perfect sweetness™
Da kann sich Sunwin mal sehen wie man sowas macht.
Die Unfähigkeit des Managments ist erschreckend.
Nur meine Meinung.
Food and Beverage Giants Lining Up to Cash in When Stevia Gets GRAS Approval in U.S.
(NaturalNews) Even though stevia has not been authorized as a food ingredient in the United States, a number of food, beverage and ingredient companies are investing significant money to expand production for what they view as its inevitable approval.
Stevia, a sweetener derived from a South American plant, is said to have approximately 300 times the sweetness of sugar, with a slower onset and longer duration. Because it has no significant effect on blood sugar and has essentially zero calories, it has attracted attention as a natural, non-synthetic sugar alternative. While stevia tends to have a slightly bitter aftertaste, producers claim to have eliminated this drawback with new processing methods.
Although the Food and Drug Association (FDA) allows stevia to be used only as an ingredient in dietary supplements, the agency has said that it expects a petition to grant stevia Generally Recognized as Safe (GRAS) status any day.
Coca-Cola has filed 24 patent applications for stevia in the United States, and has teamed up with Cargill to begin marketing the sweetener. Media reports suggest that the companies are preparing to petition the FDA.
Meanwhile, Malaysian ingredient firm PureCircle is raising $50 million to expand its stevia production by three times in the next two years. The company has already secured patents on a technique for extracting Rebaudioside-A, one of the sweeteners found in the stevia plant.
U.S. company Blue California has also developed a process for extracting Rebaudioside-A. Through comments that its process allows the price of stevia to be competitive with that of sugar, the firm has indicated that it is viewing stevia as more than a dietary supplement. While the company is only planning to begin small-scale production of the sweetener, it says that it is preparing the infrastructure to be able to scale up significantly once stevia is approved for foods and beverages.
Stevia is approved for use as a food and beverage ingredient in a handful of countries including Brazil, Canada, China and Japan.
(Autor: klickmich):
Bei einem so relativ kleinen Unternehmen(wie sunwin erg. von wolf333) ist das mit dem fairen Wert eher eine Zahlenspielerei:
Man kann wohl sicher sagen, wo das Unternehmen preiswert ist, nämlich dann wenn an der Börse weniger als die Assets abzüglich der Schulden bezahlt werden. Denn ein wertmässiger Abschlag ist an der Börse (aber letzlich auch bei private Mergers & Acquisitions für Ltds.) nur dann gerechtfertigt, wenn das Unternehmen sich ständig des Eigenkaptals bedient, um operative Schulden auszugleichen oder wenn börsennotierte Beteiligungen bestehen, die starken Wertschwankungen unterliegen.
Beides ist hier offensichtlich nicht der Fall und das Unternehmen bewegt sich ja gerade um diesen inneren Wert herum.
Nun wird an der Börse aber eigentlich die Zukunft gehandelt und die Vergangenheit dient allenfalls zur Bestätigung der Glaubwürdigkeit. Welche Zukunft nehmen wir? Ein Jahr im voraus oder 2 Jahre, also deren FY 2010?
Mit dem was sie an Produktionsanlagen stehen haben und als Großhändler in der Vergangenheit umgesetzt haben, kann man wohl ca. 40 Mio USD erlösen. Das wäre auf 2 Jahre gerechnet eine jeweilige Umsatzsteigerung von ca. 30%. Was passiert aber, wenn das Unternehmen zukauft (immerhin hatte man das mal im Jahr 2006 vorgehabt, sich 300t extern dazuzuholen) oder eine weitere Produktionsstraße hinstellt (eine 380er Qualität wird ja zumindestens angedacht), dann wären die genannten Umsatzgrössen schon wieder Makulatur, auf der anderen Seite gäbe es aber wahrscheinlich auch eine Verwässerung druch die Ausgabe neuer Aktien, um frisches Geld für diese Vorhaben zu bekommen.
Welche Rendite soll man ansetzen? 10% Nettorendite erreicht man durchaus, wenn es optimal läuft, sogar 15% (wie 2006 geschehen).
Nach den bisherigen Zahlenspielchen könnte man also im FY 2010 bis zu 6 Mio Gewinn erzielen, ergo 0,07 EPS. Nur mit welchem KGV soll man dieses Unternehmen ansetzen?
Konkurrenten im Nahrungsergänzungsbereich liegen zwischen 20 bis 30 . Wir wären hier demnach bei USD 1,40 - 2,10 und man sieht mit den ganzen wenns und vielleicht eröffnet sich ein riesiger Bewertungskorridor.
Man sollte also eher darauf achten, wie schnell Sunwin sich bewegt und dann gegebenenfalls mal die Reißleine ziehen. Eine Punktlandung wird aufgrund der Marktenge nie gelingen, mal abgesehen spielt die Börse nur oberflächlich mit der
SUNWIN USA spent close to nine months working to improve the quality of the product.
"The formulation change of OnlySweet™ represents a significant advancement in the quality of our product," said Jeff Reynolds, President and CEO of SUNWIN USA. "Consumers will notice a tremendous improvement in the taste, absence of aftertaste, and mouth feel of this blend. We feel these attributes will make it the preferred stevia product over the next 12-18 months."
In addition, OnlySweet™ will remain affordable. "When comparing the retail price of OnlySweet™ to other stevia products, consumers will find our brand will continue to provide consumers a significant savings," said Reynolds.
OnlySweet™ products are sold in boxes of 100 and 200 packets in more than 3,500 grocery stores in the United States. For more information visit www.onlysweet.com.
About Sunwin International Neutraceuticals, Inc.
Sunwin International Neutraceuticals (OTCBB: SUWN) engages in the areas of essential traditional Chinese medicine, zero calorie natural sweetener (stevia), and veterinary medicines and feeds prepared from 100 percent organic herbal ingredients. As an industry leader in agricultural processing, Sunwin has built an integrated global firm with the sourcing and production capabilities to meet the needs of consumers throughout the world. Sunwin also makes such value-added products as specialty veterinary food ingredients and specialty feed ingredients. For more info about Sunwin, please visit http://www.sunwin.biz
About OnlySweet™
OnlySweet™ is a proprietary product blended with Stevioside (stevia), an all natural, zero calorie, zero sugar, naturally sweet dietary supplement, extracted from the leaves of the stevia rebaudiana plant. OnlySweet™ is blended and packaged in the United States, and is distributed by SUNWIN USA, Inc. in over 3,500 grocery stores in the United States. Stevia is used as a food additive in a wide variety of products, such as beverages, pastries, dairy products, confections and medicinal products in Japan, China, Malaysia, Israel, South Korea, Brazil and other countries. In the United States, OnlySweet™ is a dietary supplement sold in boxes of 100 and 200 packets. It has zero calories and does not significantly alter blood sugar levels. OnlySweet™ is unique because its stevia only comes directly from Sunwin International Neutraceuticals (OTCBB: SUWN), one of the world’s largest stevia manufacturers, assuring consistency and purity.
Safe Harbor Statement
In connection with the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, Sunwin International Neutraceuticals, Inc., is hereby providing cautionary statements identifying important factors that could cause our actual results to differ materially from those projected in forward-looking statements (as defined in such act). Any statements that are not historical facts and that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance (often, but not always, indicated through the use of words or phrases such as "will likely result," "are expected to," "will continue," "is anticipated," "estimated," "intends," "plans," "believes" and "projects") may be forward-looking and may involve estimates and uncertainties which could cause actual results to differ materially from those expressed in the forward-looking statements. These statements include, but are not limited to, our guidance and expectations regarding revenues, net income and earnings. In addition, any such statements are qualified in their entirety by reference to, and are accompanied by, the following key factors that have a direct bearing on our results of operations: our ability to effectively integrate our acquisitions and to manage our growth and our inability to fully realize any anticipated benefits of acquired business; our need for additional financing which we may not be able to obtain on acceptable terms, the dilutive effect additional capital raising efforts in future periods may have on our current shareholders; our dependence on certain key personnel; the lack various legal protections in certain agreements to which we are a party and which are material to our operations which are customarily contained in similar contracts prepared in the United States; the business operating risks and new technology in the business we seek to enter into and currently operate in; the effect of changes resulting from the political and economic policies of the Chinese government on our assets and operations located in the PRC; the influence of the Chinese government over the manner in which our Chinese subsidiaries must conduct our business activities; the limitation on our ability to receive and use our revenues effectively as a result of restrictions on currency exchange in China; our ability to enforce our rights due to policies regarding the regulation of foreign investments in China; our ability to comply with the United States Foreign Corrupt Practices Act which could subject us to penalties and other adverse consequences; and our ability to establish adequate management, legal and financial controls in the PRC.
We caution that the factors described herein could cause actual results to differ materially from those expressed in any forward-looking statements we make and that investors should not place undue reliance on any such forward-looking statements. Further, any forward-looking statement speaks only as of the date on which such statement is made, and we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which such statement is made or to reflect the occurrence of anticipated or unanticipated events or circumstances. New factors emerge from time to time, and it is not possible for us to predict all of such factors. Further, we cannot assess the impact of each such factor on our results of operations or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements.
CONTACT:
Sunwin International Neutraceuticals, Inc.
Phone: 1-877-China-57
Email: info@sunwin.biz
nächste mögl news (aus der Sicht der Mail, die ich bekam)
-gute Zahlen ? --> hoffentlich
-gute Aussichten ? --> logo
-Produktionenserweiterung ? --> angedacht
-Kooperation mit BigPlayer ? --> möglich
-neue, zeitgemäße INetseiten/ Selbstdarstellung ? --> kommen bald (ist bereits heisses Thema in China
-FDA Zulassung ? --> mit der neuen Zusammenstellung doch kein Problem mehr, oder?
noch dazu:
- aggressives Marketing --> in Vorbereitung
- Kohle vorhanden? --> in Vorbereitung
Wie man sieht: es tut sich was bei sunwin...
Das FY 2008 endete am 30.4.2008.
Hat jemals ein CEO wirklich Probleme zugegeben bevor sie sowieso öffentlich sichtbar waren?
In den USA geht es doch kaum vorran, keine neuen Stores, keine neuen Kooperationen, alles nur wage Ankündigungen wie wir sie schon so lange hören. Was machen die eigentlich den ganzen lieben langen Tag?
Lieber wolf, gibs auf.
Has stevia broken US dietary supplement shackles?
By Shane Starling
KEYWORDS
* Fibres and carbohydrates
* Cardiovascular health
* Diabetes
* Immune system
LATEST NEWS HEADLINES
* SunOpta to build new soymilk plant
* FDA urged to ban artificial colors linked to hyperactivity
* Globalisation raises food safety fears, says microbiologist
* Low-dose resveratrol may slow ageing: for mice at least
* EU slaps anti-dumping duties on Chinese citric acid
GET THE LATEST MARKET REPORTS
* Wisdom Natural Brands
* Cargill
* stevia
* natural sweeteners
All market reports
04-Jun-2008 - The hype surrounding stevia has been ratcheted up another notch after the US's largest supplier announced it is launching the natural sweetener beyond the dietary supplements aisle for the first time.
Arizona-based Wisdom Natural Brands has self-affirmed its version of stevia - Sweet Leaf - as being generally regarded as safe (GRAS) and said the ingredient would be available in a soda or food product by year's end.
Wisdom Natural Brands chief executive officer and founder, Jim May, told FoodNavigator-USA.com, at least one major beverage manufacturer had shown strong interest in Sweet Leaf.
In the meantime it would be available at retail level as a table-top sweetener that would be labeled as a sweetener not a dietary supplement as has been the case in the past.
This was significant because for the first time stevia would be sold alongside other sweeteners and not among dietary supplements on store shelves.
"We have produced 40,000-50,000 units that will be on the shelf across the US in a week," May said.
The US market is estimated to be worth about $60m, a figure analysts could triple if FDA GRAS was granted, as the industry has resolved many of the taste and formulation issues that plagued the ingredient in the past.
Supply problems have also been eased as channels have opened up and been developed in places like China for stevia, which is between 250 and 400 times sweeter than regular sugar.
Building science
Wisdom Natural Brands had completed a review of available science on March 5, which had prompted it to make the self-affirmed GRAS announcement.
"We had third-party, former-FDA analysts assess the science and so feel confident about the is GRAS affirmation," he said. "We would have like to delay the announcement but there is a war of attention happening right now with Coke and Cargill's announcement so we felt we should go ahead with this now."
Coca-Cola and Cargill recently announced science backing their ingredient Truvia but have yet to bring it to market although a launch looks imminent …
May said Sweet Leaf-branded, table-top sweetener products would be on shelves by next week, and all existing Wisdom Brands sweeteners marketed as dietary supplements would be phased out except in export markets.
But Daniel Fabricant, PhD, science and regulatory affairs vice president at the Washington DC-based Natural Products Association (NPA), said Wisdom Brands was pursuing a risky strategy by pursuing incorporation into the "food matrix" without FDA GRAS approval.
May said Wisdom Natural Brands had given up waiting for such approval after first submitting a GRAS application in 1995 that included 900 studies demonstrating stevia's safety.
"Of course a company can go ahead and incorporate the ingredient into different foods without FDA approval but if the FDA cracks down on them it can be a public relations disaster," Fabricant said.
This happened in 2007 with a tea product called Celestial Seasonings the FDA determined was not labeled clearly enough as a dietary supplement, and which required re-labeling with the words 'dietary supplement' appearing more prominently.
But the fact the product remained on market in the form of a tea, highlights a regulatory grey area exists that allows products containing stevia to be labeled as dietary supplements when they are clearly being consumed in the manner of foods.
Although Coke/Cargill's science relates only to their own proprietary version of stevia, the science around the ingredient's safety is growing to the point where it is going to be increasingly difficult for FDA to refuse it, especially as consumer demand for natural low-calorie sweeteners grows.
But Fabricant suggested GRAS approval may still be some time off.
"There have been so many different studies on various chemical stevia entities that FDA has had little trouble throwing it out, so it will be interesting to see how much of an impression this new science makes," he said.
The biggest markets for stevia are Japan and Korea, where stevia has been used to sweeten diet drinks for around 20 years and is commonly used as an 'at-home' sweetener.
Stevia is derived from the South American plant stevia rebaudiana.
By Shane Starling
04-Jun-2008 - The hype surrounding stevia has been ratcheted up another notch after the US's largest supplier announced it is launching the natural sweetener beyond the dietary supplements aisle for the first time.
Arizona-based Wisdom Natural Brands has self-affirmed its version of stevia - Sweet Leaf - as being generally regarded as safe (GRAS) and said the ingredient would be available in a soda or food product by year's end.
Wisdom Natural Brands chief executive officer and founder, Jim May, told FoodNavigator-USA.com, at least one major beverage manufacturer had shown strong interest in Sweet Leaf.
In the meantime it would be available at retail level as a table-top sweetener that would be labeled as a sweetener not a dietary supplement as has been the case in the past.
This was significant because for the first time stevia would be sold alongside other sweeteners and not among dietary supplements on store shelves.
"We have produced 40,000-50,000 units that will be on the shelf across the US in a week," May said.
The US market is estimated to be worth about $60m, a figure analysts could triple if FDA GRAS was granted, as the industry has resolved many of the taste and formulation issues that plagued the ingredient in the past.
Supply problems have also been eased as channels have opened up and been developed in places like China for stevia, which is between 250 and 400 times sweeter than regular sugar.
Building science
Wisdom Natural Brands had completed a review of available science on March 5, which had prompted it to make the self-affirmed GRAS announcement.
"We had third-party, former-FDA analysts assess the science and so feel confident about the is GRAS affirmation," he said. "We would have like to delay the announcement but there is a war of attention happening right now with Coke and Cargill's announcement so we felt we should go ahead with this now."
Coca-Cola and Cargill recently announced science backing their ingredient Truvia but have yet to bring it to market although a launch looks imminent …
May said Sweet Leaf-branded, table-top sweetener products would be on shelves by next week, and all existing Wisdom Brands sweeteners marketed as dietary supplements would be phased out except in export markets.
But Daniel Fabricant, PhD, science and regulatory affairs vice president at the Washington DC-based Natural Products Association (NPA), said Wisdom Brands was pursuing a risky strategy by pursuing incorporation into the "food matrix" without FDA GRAS approval.
May said Wisdom Natural Brands had given up waiting for such approval after first submitting a GRAS application in 1995 that included 900 studies demonstrating stevia's safety.
"Of course a company can go ahead and incorporate the ingredient into different foods without FDA approval but if the FDA cracks down on them it can be a public relations disaster," Fabricant said.
This happened in 2007 with a tea product called Celestial Seasonings the FDA determined was not labeled clearly enough as a dietary supplement, and which required re-labeling with the words 'dietary supplement' appearing more prominently.
But the fact the product remained on market in the form of a tea, highlights a regulatory grey area exists that allows products containing stevia to be labeled as dietary supplements when they are clearly being consumed in the manner of foods.
Although Coke/Cargill's science relates only to their own proprietary version of stevia, the science around the ingredient's safety is growing to the point where it is going to be increasingly difficult for FDA to refuse it, especially as consumer demand for natural low-calorie sweeteners grows.
But Fabricant suggested GRAS approval may still be some time off.
"There have been so many different studies on various chemical stevia entities that FDA has had little trouble throwing it out, so it will be interesting to see how much of an impression this new science makes," he said.
The biggest markets for stevia are Japan and Korea, where stevia has been used to sweeten diet drinks for around 20 years and is commonly used as an 'at-home' sweetener.
Stevia is derived from the South American plant stevia rebaudiana.
Was und wann die entscheiden steht also völlig in den Sternen, vielleicht kriegt ja auch nur Cola die Zulassung für deren "Spezialsorte", Dollars haben die ja genug und so halten sie sich gleich die Konkurrenz vom Hals. Bei so einen korrupten Verein wie der FDA ist doch alles möglich, nur an die Verbraucher denkt da keiner. Geld regiert die Welt!
FDA Pressed by Lawsuit to Address Mercury Amalgam Safety
Beim Amalgam läuft das seit Jahrzehnten genauso. Da werden auch hartnäckig tausende von Studien ignoriert die die Gefährlichkeit von Amalgam belegen. Da geht es um Milliarden und der Verbraucher kann selber sehen wie er den Mist wieder los wird.
http://video.google.com/videoplay?docid=4610600548824595793&hl=de
Umweltgifte und Entgiftungsmöglichkeiten
